2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Re-evaluating Olfactory Testing and Cardiac 123I-MIBG Scintigraphy in the MDS Clinical Diagnostic Criteria for Parkinson’s Disease

T. Nukariya, M. Seki, T. Osada, J. Ebina, K. Suzuki, R. Sengoku, T. Hatano, H. Murakami, K. Sakuishi, M. Shiraishi, Y. Shimo, H. Terashi, H. Nagayama, H. Nakajima, K. Takahashi, S. Nogawa, Y. Okuma, F. Yoshii, M. Iijima, N. Hattori (Chiba, Japan)
Real-life accelerometer-based detection of DBS effects on tremor and dyskinesia in Parkinson’s disease, trained with ecological momentary assessments

J. Habets, V. Mathiopoulou, L. Drescher, A. Ben Janet, A. Buchwald, L. Muessig, J. Kaplan, A. Memarpouri, J. Vivien, L. Feldmann, G. Brandt, A. Kühn (Berlin, Germany)
Real-Time Quaking-Induced Conversion Detection of Tear Fluid α-Synuclein as a Potential Biomarker for Parkinson’s Disease

A. Kakimoto, K. Satoh, T. Tsukahara-Kawamura, Y. Tsuboi (Nagasaki, Japan)
Real-World Clinical Experience With Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion In Advanced Parkinson’s Disease Patients With Mild Cognitive Impairment And History Of Psychosis

MN. Afkir Ortega, E. Navarro Mocholi, I. Sastre Bataller, M. Campins Romeu, C. Morata Martínez, R. Baviera Muñoz, J. Perez Garcia, I. Martinez Torres (Valencia, Spain)
Real-World Clinical Outcomes and Patient Experience Following Hybrid DBS Conversion to a Neurostimulator with Advanced Current Steering

J. Vesper, A. Dreyer, R. Shivacharan, E. Goldberg (Düsseldorf, Germany)
Real-World Clinical Outcomes of Adaptive versus Continuous Deep Brain Stimulation in Early-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis of 2024-2025 Trials

F. Al-Zaidi (Almaty, Kazakhstan)
Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan

M. Nagai, R. Ando, K. Sasaki, Y. Tomita, K. Daidoji, Y. Kogo, T. Ishida (Tokyo, Japan)
Real-World Digital Tracking of Parkinson’s Disease

K. Muhammed, S. Mason, A. Graham, A. Macerollo, A. Hulejczuk, J. Cosgrove, D. El Kodsi, V. Khurana, M. Hu, M. Tagliati (London, United Kingdom)
Real-World Effectiveness and Safety of Deutetrabenazine in Chinese Patients With Tardive Dyskinesia

Q. Bo, A. Li, W. Dun, X. Zhang, Z. Wang, J. Li, L. Wang, W. Li, N. Li, Y. Tan, X. Xu, J. Qu, Y. Li, G. Zhang, K. Tugrul Ustundag, A. Peyser Levin, R. Ribalov, W. Lou, R. Eshet, M. Zeygarnik (Beijing, China)
Real-World Evaluation of Deutetrabenazine for Huntington Disease–Associated Chorea in South Korea: Study Design and Baseline Characteristics

M. Jung, R. Eshet, K. Tuğrul üstündağ, A. Peyser Levin (Seoul, Republic of Korea)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z